X0202 4 2005-11-07 0 0001138812 COTHERIX INC CTRX 0001257444 ALTA BIOPHARMA PARTNERS III LP ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001106287 GRUENER GARRETT ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198328 MARDUEL ALIX ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198330 NOHRA GUY P ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001276361 ALTA PARTNERS II INC ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001211840 HURWITZ EDWARD ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198332 PENHOET EDWARD ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001341610 Alta Partners III, Inc. ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2005-11-07 4 J 0 358426 0.00 D 1942611 I See footnotes Common Stock 62226 I See footnotes Common Stock 869164 I See footnotes Common Stock 58370 I See footnotes Common Stock 21415 I See footnotes Common Stock 2005-11-07 4 J 0 869 0.00 A 869 D Not applicable Alta California Partners III, L.P. ("ACPIII") distributed 358,426 shares of Common Stock to its general and limited partners based on their respective capital interest in ACPIII in accordance with the Partnership Agreement without receipt of additional consideration from such partners. As a result of the 11/7/2005 stock distribution, ACPIII now holds 1,942,611 shares of Common Stock. Daniel Janney, Director, is a managing director of Alta California Management Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII") & a manager of Alta Embarcadero Partners III, LLC ("AEPIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEPIII. He is a member of Alta BioPharma Management III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of his proportionate pecuniary interests therein. Alta Partners II, Inc. & Alta Partners III, Inc. provide investment advisory services to several funds including ACPIII, AEPIII, ABPIII, Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG") & Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The managing directors ("md") of ABMPIII (which is the gp of ABPIII & ABPIIIKG) & managers of AEBPIII, exercise sole voting & investment powers with respect to the sh ("sh")owned by such funds. G Gruener, G Nohra & D Janney (collectively known as the "principals") are md of ACMPIII & managers of AEPIII. J Deleage, F Champsi, A Marduel, E Hurwitz & E Penhoet (collectively known as the "principals") are directors of ABMPIII (which is the gp of ABPIII & ABPIIIKG & managers of AEBPIII, The principals may be deemed to share voting & investment powers over the sh held by the funds. The principals disclaim beneficial ownership of all such sh held by the funds, except to the extent of their porportionate pecuniary interest therein. Alta Embarcadero Partners III, LLC holds 62,226 shares of Common Stock. Alta BioPharma Partners III, L.P. holds 869,164 shares of Common Stock. Alta BioPharma Partners III GmbH & Co. Beteiligungs KG holds 58,370 shares of Common Stock. Alta Embarcadero BioParma Partners III, LLC holds 21,415 shares of Common Stock. As a result of the 11/7/05 stock distribution, Daniel Janney received 869 shares of Common Stock. Cross-reference to Form 4 for Daniel Janney filed on 11/08/2005. Farah Champsi, Director 2005-11-08 Farah Champsi 2005-11-08 Jean Deleage 2005-11-08 Garrett Gruener 2005-11-08 Alix Marduel 2005-11-08 Guy Nohra 2005-11-08 Jean Deleage, President 2005-11-08 Edward Hurwitz 2005-11-08 Edward Penhoet 2005-11-08 Jean Deleage, President 2005-11-08